Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jul 1998

Brambilla E, Gazzeri S, Lantuejoul S, Coll J L, Moro D, Negoescu A, Brambilla C

Abstract excerpt

Lung cancer is the end result of a multistep process in which genetic and molecular changes accompany, in an unknown temporal sequence, histological precursor (preinvasive) bronchial lesions. Biomarkers allowing prediction of the rate of progression of precursor lesions at different locations in the anatomical field may be clinically useful. Toward this aim, we analyzed, using immunohistochemistry, the expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclins
Share to Genes, p53

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Lung Neoplasms

Share to Mutation

Share to Neoplasm Proteins

Share to Proto-Oncogene Proteins

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9676834

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.PMID 9676834Read ↗

Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.Semantic proximity Read ↗

p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.Semantic proximity Read ↗

Early detection of lung cancer: role of biomarkers.Semantic proximity Read ↗

p53 and lung cancer.Semantic proximity Read ↗

Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma.Semantic proximity Read ↗

Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking.Semantic proximity Read ↗

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancerSemantic proximity Read ↗

A correlation between mutation of the p53 gene and histological heterogeneity in differentiated adenocarcinomas of the lung, with reference to stepwise progression and metastatic ability.Semantic proximity Read ↗

Prognostic value of immunohistochemical expression of p53, bax, Bcl‐2 and Bcl‐x<sub>L</sub> in resected non‐small‐cell lung cancersSemantic proximity Read ↗

Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas.Semantic proximity Read ↗

Loss of function of p16 gene and prognosis of pulmonary adenocarcinomaSemantic proximity Read ↗

BAX and p16INK4Aare independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.